Part of The Weill Cornell Graduate School of Medical Sciences. A combined program of Weill Cornell Medical College and the Sloan-Kettering Institute,we are a premiere school in Biomedical Research. We are part of Cornell University (Ithaca, NY) but Weill Cornell Medical College is located in New York City. Read more about our programs of study:
The research activities of the Cornell Pharmacology Program faculty cover broad areas of modern pharmacological sciences. Faculty carry out research in cancer pharmacology, neuropharmacology, cardiovascular pharmacology, drug metabolism, toxicology, proteomics, molecular pharmacology, receptors and signal transduction, and drug design.
PARTIES AND EVENTS
April 8, 2015:
Dr. Marcus Reidenberg, a member of the Advisory Board of the Global Healthcare Innovation Management Center of Fordham University, discussed patient-centric cancer care at an open public lecture at Fordham University.
April 1, 2015:
We welcome Dr. David Foster, the Rosalyn Yalow Professor at Hunter College, and his lab members to Pharmacology…Dr. Foster has an adjunct faculty position at WCMC, and his lab is now on the 4th floor of the Belfer Research Building.
March 9, 2015:
Dr. Francis Lee and Dr. Iva Dincheva, a former PhD student in our Pharmacology Program and now a postdoctoral fellow in Dr. Lee's lab, have published a fascinating study in Nature Communications concerning fronto-amygdala function. Congratulations!! This work was also featured in the NY Times: click here or click here
February 5, 2015:
Great news! Congratulations go to Pharm. PhD student Sara DiNapoli, who was awarded an F31 fellowship from NCI for her project titled: "Understanding the role of Polycomb Repressive Complex 2 in Melanoma." Her PhD mentor is Dr. Yariv Houvras, and co-mentor is Dr. Ari Melnick.
January 2, 2015:
Dr. Michael Peterson, a postdoctoral fellow on the Cancer Pharmacology Training Grant (Danishefsky lab), has accepted a faculty position at the College of Wooster in Wooster, Ohio. Congratulations, Mike!
December 12, 2014:
Jocelin Kalish, a Pharmacology PhD student in the Gudas lab, will receive funding from NIH for her F31 fellowship. Congratulations to Jocelin!!!
December 1, 2014:
Drs. Jaffrey and Sauve have shown that noise-induced hearing loss in a mouse can be prevented by using a simple chemical compound, nicotinamide riboside, that is a precursor to vitamin B3!! To read more: click here
Max B. Kelz, M.D., Ph.D.
Perelman School of Medicine at the University of Pennsylvania., Room: A-950
Host: Dr. Hugh Hemmings
Ralph Deberardinis, M.D., Ph.D.
New York University School of Medicine, Room: A-950
Host: Dr. Arleen Rifkind
“Understanding metabolic heterogeneity in cancer cells and tumors”
Max B. Kelz, M.D., Ph.D. Perelman School of Medicine at the University of Pennsylvania., Room: A-950 Host: Dr. Hugh Hemmings “TBA”
Ralph Deberardinis, M.D., Ph.D. New York University School of Medicine, Room: A-950 Host: Dr. Arleen Rifkind “Understanding metabolic heterogeneity in cancer cells and tumors”